Hepatitis C virus infection mediates cholesteryl ester synthesis to facilitate infectious particle production

Journal of General Virology

Volumn 95, Issue PART 9, 2014, Pages 1900-1910

  Read, Scott A ^a   Tay, Enoch ^a   Shahidi, Mahsa ^a   George, Jacob ^a   Douglas, Mark W ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACAT1 ENZYME; ACAT2 ENZYME; CALRETICULIN; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL ESTER; ENZYME; FAT DROPLET; FILIPIN; MESSENGER RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CELLULAR DISTRIBUTION; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIPID STORAGE; LIPOGENESIS; LIVER BIOPSY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RNA REPLICATION; UPREGULATION; VIRUS INFECTIVITY;

CELL LINE, TUMOR; CHOLESTEROL ESTERS; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; PHENYLUREA COMPOUNDS; RNA, MESSENGER; RNA, VIRAL; STEROL O-ACYLTRANSFERASE; UP-REGULATION; VIRUS REPLICATION;

EID: 84906256916     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.065300-0     Document Type: Article

References (51)

1. Agnello, V., Abel, G., Elfahal, M., Knight, G. B. & Zhang, Q. X. (1999). Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 96, 12766-12771.
2. Aizaki, H., Lee, K. J., Sung, V. M., Ishiko, H. & Lai, M. M. (2004). Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324, 450-461.
3. Alger, H. M., Brown, J. M., Sawyer, J. K., Kelley, K. L., Shah, R., Wilson, M. D., Willingham, M. C. & Rudel, L. L. (2010). Inhibition of acylcoenzyme A: cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization. J Biol Chem 285, 14267-14274.
4. Alter, M. J. (1997). Epidemiology of hepatitis C. Hepatology 26 (Suppl. 1), 62S-65S.
5. Bartenschlager, R., Penin, F., Lohmann, V. & André, P. (2011). Assembly of infectious hepatitis C virus particles. Trends Microbiol 19, 95-103.
6. Boulant, S., Targett-Adams, P. & McLauchlan, J. (2007). Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J Gen Virol 88, 2204-2213.
7. Clark, P. J., Thompson, A. J., Vock, D. M., Kratz, L. E., Tolun, A. A., Muir, A. J., McHutchison, J. G., Subramanian, M., Millington, D. M. & other authors (2012). Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. Hepatology 56, 49-56.
8. Counihan, N. A., Rawlinson, S. M. & Lindenbach, B. D. (2011). Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog 7, e1002302.
9. Czaja, A. J., Carpenter, H. A., Santrach, P. J. & Moore, S. B. (1998). Host-and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 29, 198-206.
10. Egger, D., Wölk, B., Gosert, R., Bianchi, L., Blum, H. E., Moradpour, D. & Bienz, K. (2002). Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 76, 5974-5984.
11. Forde, K. A., Law, C., O'Flynn, R. & Kaplan, D. E. (2009). Do statins reduce hepatitis C RNA titers during routine clinical use? World J Gastroenterol 15, 5020-5027.
12. Foster, G. R., Hézode, C., Bronowicki, J. P., Carosi, G., Weiland, O., Verlinden, L., van Heeswijk, R., van Baelen, B., Picchio, G. & Beumont, M. (2011). Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections. Gastroenterology 141, 881-889. e1.
13. Harris, C., Herker, E., Farese, R. V., Jr & Ott, M. (2011). Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis. J Biol Chem 286, 42615-42625.
14. Hope, R. G. & McLauchlan, J. (2000). Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J Gen Virol 81, 1913-1925.
15. Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A. & Powell, E. E. (1999). Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29, 1215-1219.
16. Huang, H., Sun, F., Owen, D. M., Li, W., Chen, Y., Gale, M., Jr & Ye, J. (2007). Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 104, 5848-5853.
17. Hui, J. M., Kench, J., Farrell, G. C., Lin, R., Samarasinghe, D., Liddle, C., Byth, K. & George, J. (2002). Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection. J Gastroenterol Hepatol 17, 873-881.
18. Icard, V., Diaz, O., Scholtes, C., Perrin-Cocon, L., Ramière, C., Bartenschlager, R., Penin, F., Lotteau, V. & André, P. (2009). Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS ONE 4, e4233.
19. Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z. & other authors (2013). Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 368, 1878-1887.
20. Lee, R. G., Willingham, M. C., Davis, M. A., Skinner, K. A. & Rudel, L. L. (2000). Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J Lipid Res 41, 1991-2001.
21. Lee, R. G., Shah, R., Sawyer, J. K., Hamilton, R. L., Parks, J. S. & Rudel, L. L. (2005). ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice. J Lipid Res 46, 1205-1212.
22. Merz, A., Long, G., Hiet, M. S., Brügger, B., Chlanda, P., Andre, P., Wieland, F., Krijnse-Locker, J. & Bartenschlager, R. (2011). Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem 286, 3018-3032.
23. Meuwese, M. C., de Groot, E., Duivenvoorden, R., Trip, M. D., Ose, L., Maritz, F. J., Basart, D. C., Kastelein, J. J., Habib, R. & other authors (2009). ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. JAMA 301, 1131-1139.
24. Miller, S. & Krijnse-Locker, J. (2008). Modification of intracellular membrane structures for virus replication. Nat Rev Microbiol 6, 363-374.
25. Milliat, F., Férézou, J., Delhon, A. & Lutton, C. (2001). Overexpression of SR-BI in hamsters treated with a novel ACAT inhibitor (F12511). C R Acad Sci III 324, 229-234.
26. Mirandola, S., Realdon, S., Iqbal, J., Gerotto, M., Dal Pero, F., Bortoletto, G., Marcolongo, M., Vario, A., Datz, C. & other authors (2006). Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 130, 1661-1669.
27. Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Wakita, T., Hijikata, M. & Shimotohno, K. (2007). The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9, 1089-1097.
28. Negro, F. (2010). Hepatitis C virus-induced steatosis: an overview. Dig Dis 28, 294-299.
29. Nielsen, S. U., Bassendine, M. F., Burt, A. D., Martin, C., Pumeechockchai, W. & Toms, G. L. (2006). Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80, 2418-2428.
30. Nissen, S. E., Tuzcu, E. M., Brewer, H. B., Sipahi, I., Nicholls, S. J., Ganz, P., Schoenhagen, P., Waters, D. D., Pepine, C. J. & other authors (2006). Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 354, 1253-1263.
31. Ohshiro, T., Matsuda, D., Sakai, K., Degirolamo, C., Yagyu, H., Rudel, L. L., Omura, S., Ishibashi, S. & Tomoda, H. (2011). Pyripyropene A, an acyl-coenzyme A: cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia. Arterioscler Thromb Vasc Biol 31, 1108-1115.
32. Paul, D., Hoppe, S., Saher, G., Krijnse-Locker, J. & Bartenschlager, R. (2013). Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J Virol 87, 10612-10627.
33. Perlemuter, G., Sabile, A., Letteron, P., Vona, G., Topilco, A., Chrétien, Y., Koike, K., Pessayre, D., Chapman, J. & other authors (2002). Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 16, 185-194.
34. Peyrou, M., Clément, S., Maier, C., Bourgoin, L., Branche, E., Conzelmann, S., Kaddai, V., Foti, M. & Negro, F. (2013). PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism. J Hepatol 59, 420-426.
35. Poynard, T., Ratziu, V., McHutchison, J., Manns, M., Goodman, Z., Zeuzem, S., Younossi, Z. & Albrecht, J. (2003). Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 38, 75-85.
36. Pramfalk, C., Angelin, B., Eriksson, M. & Parini, P. (2007). Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells. Biochem Biophys Res Commun 364, 402-409.
37. Romero-Brey, I., Merz, A., Chiramel, A., Lee, J. Y., Chlanda, P., Haselman, U., Santarella-Mellwig, R., Habermann, A., Hoppe, S. & other authors (2012). Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog 8, e1003056.
38. Sainz, B., Jr, Barretto, N., Martin, D. N., Hiraga, N., Imamura, M., Hussain, S., Marsh, K. A., Yu, X., Chayama, K. & other authors (2012). Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18, 281-285.
39. Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R. & Vitelli, A. (2002). The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21, 5017-5025.
40. Scholtes, C., Ramière, C., Rainteau, D., Perrin-Cocon, L., Wolf, C., Humbert, L., Carreras, M., Guironnet-Paquet, A., Zoulim, F. & other authors (2012). High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients. Hepatology 56, 39-48.
41. Serfaty, L., Andreani, T., Giral, P., Carbonell, N., Chazouillères, O. & Poupon, R. (2001). Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 34, 428-434.
42. Shavinskaya, A., Boulant, S., Penin, F., McLauchlan, J. & Bartenschlager, R. (2007). The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 282, 37158-37169.
43. Siagris, D., Christofidou, M., Theocharis, G. J., Pagoni, N., Papadimitriou, C., Lekkou, A., Thomopoulos, K., Starakis, I., Tsamandas, A. C. & Labropoulou-Karatza, C. (2006). Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat 13, 56-61.
44. Sugiyama, Y., Odaka, H., Itokawa, S., Ishikawa, E., Tomari, Y. & Ikeda, H. (1995). TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters. Atherosclerosis 118, 145-153.
45. Tabas, I. (2002). Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 110, 905-911.
46. Temel, R. E., Hou, L., Rudel, L. L. & Shelness, G. S. (2007). ACAT2 stimulates cholesteryl ester secretion in apoB-containing lipoproteins. J Lipid Res 48, 1618-1627.
47. van der Wulp, M. Y., Verkade, H. J. & Groen, A. K. (2013). Regulation of cholesterol homeostasis. Mol Cell Endocrinol 368, 1-16.
48. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H. G. & other authors (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796.
49. Woodhouse, S. D., Narayan, R., Latham, S., Lee, S., Antrobus, R., Gangadharan, B., Luo, S., Schroth, G. P., Klenerman, P. & Zitzmann, N. (2010). Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology 52, 443-453.
50. Ye, J., Wang, C., Sumpter, R., Jr, Brown, M. S., Goldstein, J. L. & Gale, M., Jr (2003). Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci U S A 100, 15865-15870.
51. Yu-Poth, S., Yin, D., Zhao, G., Kris-Etherton, P. M. & Etherton, T. D. (2004). Conjugated linoleic acid upregulates LDL receptor gene expression in HepG2 cells. J Nutr 134, 68-71.